3-(((R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl)methyl)-2-(4-(1-methyl-1H-indazol-5-yl)phenyl)-7-oxa-1,3-diazaspiro[4.4]non-1-en-4-one

ID: ALA4130221

PubChem CID: 89993534

Max Phase: Preclinical

Molecular Formula: C29H31N5O3

Molecular Weight: 497.60

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cn1ncc2cc(-c3ccc(C4=NC5(CCOC5)C(=O)N4C[C@@H]4CCN(C(=O)C5CC5)C4)cc3)ccc21

Standard InChI:  InChI=1S/C29H31N5O3/c1-32-25-9-8-23(14-24(25)15-30-32)20-2-4-21(5-3-20)26-31-29(11-13-37-18-29)28(36)34(26)17-19-10-12-33(16-19)27(35)22-6-7-22/h2-5,8-9,14-15,19,22H,6-7,10-13,16-18H2,1H3/t19-,29?/m1/s1

Standard InChI Key:  MUYLYGDFLYUIJG-COBFLCELSA-N

Molfile:  

     RDKit          2D

 37 43  0  0  0  0  0  0  0  0999 V2000
   15.2297  -23.8779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5198  -23.4693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9118  -24.0181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2460  -24.7660    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0604  -24.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1862  -24.1540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0058  -24.1551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1826  -22.7432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7753  -23.4524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9587  -23.4567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5486  -22.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7280  -22.7465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3166  -23.4601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7358  -24.1689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5550  -24.1634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0053  -22.7404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4159  -23.4479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2159  -23.2706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2972  -22.4560    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5474  -22.1284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8300  -23.8187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4953  -23.4637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0096  -22.8033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.2334  -23.0592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0153  -24.1296    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.2627  -22.0208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0653  -21.8473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6778  -22.3873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3837  -21.9755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2101  -21.1727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3929  -21.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7582  -20.5588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5625  -20.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5021  -19.7786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1751  -21.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3413  -20.4645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5671  -22.5762    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  2  0
  7 17  1  0
 16  8  1  0
  8  9  2  0
  9  6  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 18 21  1  0
 13 22  1  0
 22 23  1  0
 23 24  1  0
 24  1  1  0
  1 25  1  0
 25 22  2  0
 23 26  1  0
 27 26  1  1
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 27  1  0
 30 32  1  0
 32 33  1  0
 32 34  2  0
 35 33  1  0
 36 35  1  0
 33 36  1  0
 24 37  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4130221

   3-[[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]methyl]-2-[4-(1-methylindazol-5-yl)phenyl]-7-oxa-1,3-diazaspiro[4.4]non-1-en-4-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 497.60

Molecular Weight (Monoisotopic): 497.2427

AlogP: 3.25

#Rotatable Bonds: 5

Polar Surface Area: 80.03

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.65

CX LogP: 2.29

CX LogD: 2.29

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.54

Np Likeness Score: -1.08

References

1. Lu T, Schubert C, Cummings MD, Bignan G, Connolly PJ, Smans K, Ludovici D, Parker MH, Meyer C, Rocaboy C, Alexander R, Grasberger B, De Breucker S, Esser N, Fraiponts E, Gilissen R, Janssens B, Peeters D, Van Nuffel L, Vermeulen P, Bischoff J, Meerpoel L..  (2018)  Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy.,  28  (12): [PMID:29779975] [10.1016/j.bmcl.2018.05.014]

Source

Source(1):

• Scientific Literature